1 |
|
NAD metabolism, sirtuins and aging
|
11 |
2.169 |
SuperPathway |
- NAD metabolism, sirtuins and aging
|
Genes names |
|
Pathways |
- NAD metabolism, sirtuins and aging
|
|
2 |
|
NAD metabolism
|
58 |
1.176 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 4
- Sirtuin 5
- Sirtuin 6
- Sirtuin 7
|
|
3 |
|
p53 Signaling
|
117 |
1.176 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 4
- Sirtuin 5
- Sirtuin 6
- Sirtuin 7
|
|
4 |
|
DNA damage_NHEJ mechanisms of DSBs repair
|
24 |
1.176 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 4
- Sirtuin 5
- Sirtuin 6
- Sirtuin 7
|
|
5 |
|
4-1BB Pathway
|
173 |
1.176 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 4
- Sirtuin 5
- Sirtuin 6
- Sirtuin 7
|
|
6 |
|
Chromatin Regulation / Acetylation
|
255 |
1.088 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 5
- Sirtuin 6
- Sirtuin 7
|
|
7 |
|
Signaling events mediated by HDAC Class III
|
38 |
0.889 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 7
|
|
8 |
|
NAD metabolism in oncogene-induced senescence and mitochondrial dysfunction-associated senescence
|
17 |
0.889 |
Genes names |
- Sirtuin 1
- Sirtuin 2
- Sirtuin 3
- Sirtuin 5
|
|
9 |
|
Transcriptional activation of mitochondrial biogenesis
|
95 |
0.770 |
Genes names |
- Sirtuin 3
- Sirtuin 4
- Sirtuin 5
|
|
10 |
|
Organelle biogenesis and maintenance
|
296 |
0.770 |
Genes names |
- Sirtuin 3
- Sirtuin 4
- Sirtuin 5
|
|
11 |
|
Glucose / Energy Metabolism
|
307 |
0.770 |
Genes names |
- Sirtuin 1
- Sirtuin 3
- Sirtuin 5
|
|
12 |
|
Gene expression (Transcription)
|
1546 |
0.628 |
|
13 |
|
SREBF and miR33 in cholesterol and lipid homeostasis
|
16 |
0.628 |
|
14 |
|
Energy metabolism
|
47 |
0.628 |
|
15 |
|
FOXO-mediated transcription
|
65 |
0.628 |
|
16 |
|
Apoptosis and Autophagy
|
185 |
0.444 |
|
17 |
|
Regulation of retinoblastoma protein
|
56 |
0.444 |
|
18 |
|
Circadian Clock
|
85 |
0.444 |
|
19 |
|
HIF-2-alpha transcription factor network
|
30 |
0.444 |
|
20 |
|
AMP-activated protein kinase signaling
|
100 |
0.444 |
|
21 |
|
Interactions between LOXL4 and oxidative stress pathway
|
18 |
0.444 |
|
22 |
|
p73 transcription factor network
|
76 |
0.444 |
|
23 |
|
Metformin Pathway, Pharmacodynamics
|
36 |
0.444 |
|
24 |
|
3q29 copy number variation syndrome
|
62 |
0.444 |
|
25 |
|
Cellular response to heat stress
|
89 |
0.444 |
|
26 |
|
Cellular responses to stimuli
|
802 |
0.444 |
|
27 |
|
FoxO family signaling
|
31 |
0.444 |
|
28 |
|
Notch Signaling Pathways
|
100 |
0.444 |
|
29 |
|
Somatroph axis (GH) and its relationship to dietary restriction and aging
|
5 |
0.444 |
|
30 |
|
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
|
122 |
0.444 |
|
31 |
|
Metabolism of steroids
|
194 |
0.444 |
|
32 |
|
CAMKK2 pathway
|
31 |
0.444 |
|
33 |
|
Primary ovarian insufficiency
|
170 |
0.444 |
|
34 |
|
Caloric restriction and aging
|
9 |
0.444 |
|
35 |
|
MAPK Signaling: Oxidative Stress
|
79 |
0.444 |
|
36 |
|
Melatonin metabolism and effects
|
31 |
0.444 |
|
37 |
|
Thyroid hormones production and peripheral downstream signaling effects
|
83 |
0.444 |
|
38 |
|
Pre-NOTCH Expression and Processing
|
235 |
0.444 |
|
39 |
|
Inclusion body myositis
|
10 |
0.444 |
|
40 |
|
Integrated breast cancer pathway
|
150 |
0.444 |
|
41 |
|
Regulation of Androgen receptor activity
|
49 |
0.444 |
|
42 |
|
Separation of Sister Chromatids
|
237 |
0.444 |
|
43 |
|
Homology Directed Repair
|
346 |
0.444 |
|
44 |
|
Prostaglandin and leukotriene metabolism in senescence
|
27 |
0.444 |
|
45 |
|
E2F transcription factor network
|
66 |
0.444 |
|
46 |
|
Thermogenesis
|
108 |
0.444 |
|
47 |
|
DYRK1A involvement regarding cell proliferation in brain development
|
62 |
0.444 |
|
48 |
|
SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction
|
17 |
0.444 |
|
49 |
|
Signal Transduction
|
2590 |
0.444 |
|
50 |
|
Cell Cycle, Mitotic
|
691 |
0.444 |
|
51 |
|
RNA Polymerase I Promoter Opening
|
509 |
0.444 |
|